批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2002/07/17 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
;Orphan
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/07/28 |
SUPPL-48(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2025/05/21 |
SUPPL-47(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2024/11/18 |
SUPPL-46(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2024/05/22 |
SUPPL-44(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2024/01/16 |
SUPPL-43(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2023/04/04 |
SUPPL-42(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2022/08/22 |
SUPPL-40(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2022/02/09 |
SUPPL-39(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2021/12/09 |
SUPPL-38(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2021/08/12 |
SUPPL-36(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2021/02/11 |
SUPPL-35(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2020/09/25 |
SUPPL-32(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
;Orphan
|
|
|
| 2020/07/21 |
SUPPL-34(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
;Orphan
|
|
|
| 2020/07/21 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2019/05/09 |
SUPPL-31(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2018/10/26 |
SUPPL-30(补充) |
Approval |
Efficacy-New Patient Population |
PRIORITY
;Orphan
|
|
|
| 2017/11/16 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/04/19 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
N/A
;Orphan
|
|
|
| 2017/01/26 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2016/06/23 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/08/17 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/07/15 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/02/27 |
SUPPL-15(补充) |
Approval |
REMS-Proposal,Labeling |
STANDARD
|
|
|
| 2015/02/23 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2014/04/11 |
SUPPL-19(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2013/12/20 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2012/12/17 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/11/13 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/06/30 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2005/11/18 |
SUPPL-5(补充) |
Approval |
Efficacy-New Indication |
UNKNOWN
|
|
|
| 2005/09/16 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/11/04 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:SODIUM OXYBATE; 剂型/给药途径:SOLUTION;ORAL; 规格:0.5GM/ML; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021196 |
001 |
NDA |
XYREM |
SODIUM OXYBATE |
SOLUTION;ORAL |
0.5GM/ML |
Prescription |
Yes |
Yes |
AA |
2002/07/17
|
JAZZ PHARMS |
| 203631 |
001 |
ANDA |
SODIUM OXYBATE |
SODIUM OXYBATE |
SOLUTION;ORAL |
0.5GM/ML |
Prescription |
No |
No |
AA |
2025/09/10
|
AMNEAL |
| 210523 |
001 |
ANDA |
SODIUM OXYBATE |
SODIUM OXYBATE |
SOLUTION;ORAL |
0.5GM/ML |
Prescription |
No |
No |
AA |
2025/11/05
|
ASCENT PHARMS INC |